Now trading at a price of $70.93, Altria has moved 1.5% so far today.
Altria returned gains of 24.1% last year, with its stock price reaching a high of $74.56 and a low of $54.7. Over the same period, the stock underperformed the S&P 500 index by -1.5%. The company's 50-day average price was $67.07. Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. Based in Richmond, VA, the Large-Cap Consumer Defensive company has 5,900 full time employees. Altria has offered a 6.0% dividend yield over the last 12 months.
The Company's Revenues Are Declining:
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue (M) | $26,153 | $26,013 | $25,096 | $24,483 | $24,018 | $23,279 |
| Gross Margins | 50% | 54% | 56% | 57% | 60% | 62% |
| Net Margins | 17% | 10% | 23% | 33% | 47% | 30% |
| Net Income (M) | $4,467 | $2,475 | $5,764 | $8,130 | $11,264 | $6,947 |
| Net Interest Expense (M) | -$1,209 | -$1,162 | -$1,058 | -$989 | -$1,037 | -$1,079 |
| Depreciation & Amort. (M) | $185 | $172 | $153 | $144 | $147 | $134 |
| Diluted Shares (M) | 1,859 | 1,845 | 1,804 | 1,777 | 1,718 | 1,683 |
| Earnings Per Share | $2.4 | $1.34 | $3.19 | $4.57 | $6.54 | $4.12 |
| EPS Growth | n/a | -44.17% | 138.06% | 43.26% | 43.11% | -37.0% |
| Avg. Price | $32.36 | $39.92 | $45.69 | $40.34 | $52.07 | $68.61 |
| P/E Ratio | 13.48 | 29.79 | 14.32 | 8.83 | 7.96 | 16.65 |
| Free Cash Flow (M) | $8,154 | $8,236 | $8,051 | $9,091 | $8,611 | $9,074 |
| CAPEX (M) | $231 | $169 | $205 | $196 | $142 | $216 |
| EV / EBITDA | 7.79 | 8.42 | 8.88 | 8.19 | 10.11 | 13.83 |
| Total Debt (M) | $30,971 | $29,149 | $28,236 | $27,354 | $26,453 | $27,278 |
| Net Debt / EBITDA | 2.35 | 2.1 | 2.01 | 2.02 | 2.05 | 2.27 |
| Current Ratio | 0.79 | 0.71 | 0.84 | 0.49 | 0.51 | 0.65 |
Altria has wider gross margins than its peer group and positive EPS growth. Additionally, the company's financial statements display generally positive cash flows and healthy leverage levels. However, the firm suffers from declining revenues and a flat capital expenditure trend and not enough current assets to cover current liabilities because its current ratio is 0.65.
Altria Is Currently Undervalued:
Altria has a trailing twelve month P/E ratio of 14.0, compared to an average of 25.91 for the Consumer Defensive sector. Based on its EPS guidance of $5.86, the company has a forward P/E ratio of 11.4. The 13.6% compound average growth rate of Altria's historical and projected earnings per share yields a PEG ratio of 1.03. This implies that the shares are fairly valued.
Altria Has an Analyst Consensus of Little Upside Potential:
The 11 analysts following Altria have set target prices ranging from $50.0 to $82.0 per share, for an average of $69.0 with a hold rating.
Altria has an average amount of shares sold short because 2.8% of the company's shares are sold short. Institutions own 63.7% of the company's shares, and the insider ownership rate stands at 0.13%, suggesting a small amount of insider investors. The largest shareholder is Blackrock Inc., whose 8% stake in the company is worth $9,207,371,986.
